⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Fresh Off Its Nasdaq Debut, a Regenerative-Medicine Upstart Is Stacking Its Board With Big-Pharma Firepower
prnewswire.com
SNN
ABBV
CNXU
SYK
ESTA
Allergan Aesthetics Receives U.S. FDA Approval for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
prnewswire.com
ABBV
Listening Sets Leaders Apart at the Fortune Best Workplaces in New York, Texas, Chicago, and the Bay Area
globenewswire.com
ABBV
CSCO
NVDA
CDNS
CRM
BOX
AXP
CPT
Next Generation Drug Conjugates Market Expected to Reach USD 42.55 Billion by 2035 | MarketsandMarkets™
globenewswire.com
AZN
NVS
ALNY
GILD
ABBV
IONS
SNY
Retinal Vein Occlusion Treatment Disease Market Size Worth USD 5.28 Billion by 2035, Expanding at a 6.44% CAGR – SNS Insider
globenewswire.com
REGN
ABBV
AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
prnewswire.com
ABBV
AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results
prnewswire.com
ABBV
Antibody Partnering Surges into 2026: Q1 Deals Top $36 Billion as Bispecifics and Discovery Platforms Drive Competition
globenewswire.com
ABBV
LLY
MRK
NVS
PFE
SNY
GILD
BMY
JNJ
UCB
Bitget 持续推进股票现货扩容，新增 30 个主流市场主题资产
globenewswire.com
ABBV
ADP
BKSY
BWXT
CAVA
CLSD
CGNX
CRSP
DIS
DUOL
HIMX
HPE
KO
LCID
LMT
ROKU
Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight
globenewswire.com
NVS
TLX
PFE
EXEL
LLY
XNCR
BTE
ORIC
MRK
ABBV
BMY
AZN
AMGN